Jones Financial Companies’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Jones Financial Companies’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$813K	Buy	24,572 +3,956	+19%	+$119K	﹤0.01%	1997
2026 Q1	$576K	Buy	20,616 +1,120	+6%	+$32.5K	﹤0.01%	1971
2025 Q4	$511K	Buy	19,496 +5,870	+43%	+$151K	﹤0.01%	1511
2025 Q3	$310K	Buy	13,626 +4,892	+56%	+$108K	﹤0.01%	1606
2025 Q2	$179K	Buy	8,734 +797	+10%	+$16.1K	﹤0.01%	1702
2025 Q1	$167K	Buy	7,937 +3,899	+97%	+$87K	﹤0.01%	1562
2024 Q4	$91.4K	Buy	4,038 +31	+0.8%	+$744	﹤0.01%	1654
2024 Q3	$98.4K	Buy	4,007 +78	+2%	+$1.9K	﹤0.01%	1408
2024 Q2	$90.8K	Buy	+3,929	New	+$92K	﹤0.01%	1082

Other funds holding IDNA

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

PGA

Portland Global Advisors Portland, Maine $1.05B AUM 18.22% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Trek Financial Scottsdale, Arizona $2.01B AUM 53.49% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jones Financial Companies's IDNA Position: Q2 2026 in Review

Jones Financial Companies increased its iShares Genomics Immunology and Healthcare ETF (IDNA) stake by 19% in Q2 2026, buying an estimated $119K and bringing the position to 24,572 shares worth $813K. The position accounts for ﹤0.01% of the portfolio, ranked #1997.

Jones Financial Companies first reported a position in IDNA in Q2 2024 and has held it in 9 quarters since. 66 funds tracked by Wall St. Rank hold IDNA as of Q2 2026.

Jones Financial Companies held 24,572 shares of iShares Genomics Immunology and Healthcare ETF worth $813K as of Q2 2026.
Jones Financial Companies bought 3,956 iShares Genomics Immunology and Healthcare ETF shares in Q2 2026, an estimated $119K.
iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #1997 holding.
Jones Financial Companies first reported a position in iShares Genomics Immunology and Healthcare ETF in Q2 2024 and has held it in 9 quarters since.
66 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.